Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-02-12
1996-10-15
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 175, 536 176, 536 179, A61K 3170, C07H 1100
Patent
active
055654339
ABSTRACT:
There is provided novel sulfated p-glycolipid compounds of the formula ##STR1## wherein R is an acyl residue of a fatty acid;
R.sup.1 is --(CH.dbd.CH).sub.m --(CH.sub.2).sub.n --CH.sub.3 ;
R.sup.2, R.sup.3, R.sup.4 and R.sup.6 each are independently --SO.sub.3 H, hydrogen, unsubstituted or substituted alkanoyl, arylalkyl or arylcarbonyl wherein said substituent is selected from the group consisting of halogen, C.sub.1-4 alkyl, trifluoromethyl, hydroxy and C.sub.1-4 alkoxy; or R.sub.4 and R.sub.6, taken together are isopropylidene; provided at least two of R.sup.2, R.sup.3, R.sup.4 and R.sup.6 are --SO.sub.3 H;
R.sup.5 is hydrogen, unsubstituted or substituted alkanoyl, arylalkyl or arylcarbonyl wherein said substituent is selected from the group consisting of halogen, C.sub.1-4 alkyl, trifluoromethyl, hydroxy and C.sub.1-4 alkoxy;
m is an integer of 0 or 1;
n is an integer of from 5 to 14, inclusive;
or a non-toxic pharmaceutically acceptable salt, solvate or hydrate thereof which are inhibitors of selectin-mediated cellular adhesion and are useful in the treatment or prevention of inflammatory diseases and other pathological conditions in mammals.
REFERENCES:
patent: 4937328 (1990-06-01), Schmidt et al.
patent: 4952683 (1990-08-01), Tschannen et al.
patent: 5211937 (1993-05-01), Brandley et al.
Springer Nature 1990, 346, 425-434.
Green et al. Biochem. Biophys. Res. Commun. 1992, 188(1), 244-251.
PNAS vol. 90 No. 4 (1993) Meedhaur et al.
Biotechnology vol. 9 (1991) Hodgson.
Hsu-Lin, S., et al., J. Biol. Chem., 259, 9121-9126 (1984).
Stenberg, P. E., J. Cell Biol., 101, 880-886 (1985).
McEver, R. P., et al., J. Clin. Invest., 84, 92-99 (1989).
Bonfanti, R., et al., Blood, 73, 1109-1112 (1989).
Hattori, R., et al., J. Biol. Chem., 264, 7768-7771 (1989).
Hattori, R., et al., J. Biol. Chem., 264, 9053-9060 (1989).
Patel, K. D., et al., J. Cell Biol., 112, 749-759 (1991).
Larsen, E., et al., Cell, 63, 467-474 (1990).
Erbe, V. E., et al., J. Cell Biol., 119, 215-217 (1992).
Skinner, M. P., et al., Biochem. Biophys. Res. Commun., 164, 1373-1379 (1989).
Skinner, M. P., et al., J. Biol. Chem., 266, 5371-5374 (1991).
Aruffo, A., et al., Cell, 67, 35-44 (1991).
Y. Suzuki, et al., Biochem. Biophys. Res. Commun., 190, 426-434 (1993).
M. S. Mulligan, et al., Nature, 364, 149-151 (1993).
Radin, N. S., Handbook of Neurochemistry, 3, 415-424 (1969).
Sweeley, C. C., Pure and Appl. Chem., 61(7) 1307-1312 (1989).
Aruffo Alejandro A.
Banville Jacques
Martel Alain
Algieri Aldo A.
Bristol--Myers Squibb Company
Fonda Kathleen Kahler
Kunz Gary L.
LandOfFree
Sulfated .beta.-glycolipid derivatives as cell adhesion inhibito does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfated .beta.-glycolipid derivatives as cell adhesion inhibito, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfated .beta.-glycolipid derivatives as cell adhesion inhibito will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1246133